Functional evidence of atypical β3‐adrenoceptors in the human colon using the β3‐selective adrenoceptor antagonist, SR 59230A
Open Access
- 1 April 1996
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 117 (7) , 1374-1376
- https://doi.org/10.1111/j.1476-5381.1996.tb15294.x
Abstract
The role of β3-adrenoceptors in human colonic circular smooth muscle was assessed in vitro by use of the β2-selective antagonist SR 59230A. Isoprenaline, in the presence of the selective β-adrenoceptor antagonists CGP 20712A (β1) and ICI 118551 (β2), both at 0.1 μ, concentration-dependently relaxed the preparation (pEC50 = 5.22). This effect was potently and competitively antagonized by SR 59230A with a pA2 of 8.31, while its R,R enantiomer SR 59483A gave an apparent pKB of 6.21. Relaxation was likewise produced by CGP 12177A (pEC50 = 6.05), but not by BRL 37344. Although only one of these β3-selective agonists was effective, the remarkably high potency of SR 59230A as a stereospecific antagonist of non-β1 non-β2 relaxation of human colonic muscle by isoprenaline provides strong functional evidence of β3-adrenoceptors in that tissue.Keywords
This publication has 3 references indexed in Scilit:
- β3‐adrenoceptors and intestinal motilityFundamental & Clinical Pharmacology, 1995
- Mediation of most atypical effects by species homologues of the β3‐adrenoceptorBritish Journal of Pharmacology, 1994
- Tissue distribution of beta 3-adrenergic receptor mRNA in man.Journal of Clinical Investigation, 1993